| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,574 |
3,117 |
$43K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
15,639 |
6,518 |
$31K |
| 80053 |
Comprehensive metabolic panel |
9,891 |
5,228 |
$28K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,636 |
1,508 |
$15K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,850 |
8,782 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
454 |
423 |
$8K |
| 83735 |
|
10,606 |
3,640 |
$6K |
| 87040 |
|
1,576 |
1,182 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
194 |
176 |
$5K |
| 84484 |
|
3,106 |
2,182 |
$4K |
| 85610 |
|
4,543 |
3,051 |
$3K |
| 85027 |
|
7,773 |
2,577 |
$3K |
| 82962 |
|
12,406 |
1,605 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,147 |
1,026 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
146 |
109 |
$3K |
| 80076 |
|
3,114 |
2,598 |
$3K |
| 81001 |
|
4,975 |
4,388 |
$2K |
| 83605 |
|
1,504 |
957 |
$2K |
| 85730 |
|
4,503 |
2,849 |
$2K |
| 87070 |
|
1,559 |
1,293 |
$2K |
| 82803 |
|
1,574 |
460 |
$2K |
| 84703 |
|
3,267 |
3,014 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,684 |
2,355 |
$2K |
| 86850 |
|
2,369 |
1,802 |
$1K |
| 84100 |
|
4,846 |
1,757 |
$1K |
| 87186 |
|
913 |
743 |
$1K |
| 83690 |
|
2,550 |
2,142 |
$969.60 |
| 82607 |
|
529 |
492 |
$859.11 |
| 87077 |
|
769 |
612 |
$810.13 |
| 80061 |
Lipid panel |
676 |
637 |
$686.82 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
165 |
161 |
$580.79 |
| 86900 |
|
2,484 |
1,905 |
$570.83 |
| 82550 |
|
812 |
486 |
$558.39 |
| 80202 |
|
125 |
49 |
$479.38 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
361 |
354 |
$435.57 |
| 86901 |
|
2,486 |
1,906 |
$393.36 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,640 |
1,324 |
$380.59 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
654 |
616 |
$317.26 |
| 83880 |
|
629 |
410 |
$289.02 |
| 80306 |
|
544 |
482 |
$275.66 |
| 86920 |
|
14 |
12 |
$249.56 |
| 85060 |
|
14 |
12 |
$199.39 |
| 87205 |
|
837 |
599 |
$198.84 |
| 86141 |
|
139 |
107 |
$168.77 |
| 85379 |
|
284 |
228 |
$118.68 |
| 82746 |
|
163 |
158 |
$104.66 |
| 82728 |
|
133 |
112 |
$97.09 |
| 87420 |
|
50 |
50 |
$86.91 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
31 |
30 |
$71.19 |
| 82140 |
|
27 |
13 |
$52.64 |
| 84702 |
|
28 |
26 |
$51.14 |
| 81025 |
|
31 |
31 |
$46.30 |
| 85652 |
|
105 |
93 |
$37.19 |
| 83540 |
|
80 |
78 |
$32.47 |
| 84439 |
|
84 |
80 |
$31.20 |
| 87081 |
|
33 |
30 |
$17.80 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
47 |
36 |
$10.42 |
| 80069 |
|
80 |
12 |
$7.80 |
| 84165 |
|
16 |
14 |
$6.48 |
| 82150 |
|
19 |
12 |
$4.85 |
| 85018 |
|
43 |
25 |
$2.88 |
| 82330 |
|
18 |
13 |
$1.82 |
| 83615 |
|
22 |
13 |
$0.81 |
| 84145 |
|
22 |
13 |
$0.00 |